The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 20, 2018
Filed:
Feb. 19, 2016
Enzychem Lifesciences Corporation, Seoul, KR;
Korea Research Institute of Bioscience and Biotechnology, Daejeon, KR;
Jae Wha Kim, Daejeon, KR;
Sei Ryang Oh, Daejeon, KR;
Kyung Seop Ahn, Daejeon, KR;
Ho Bum Kang, Daejeon, KR;
Beom Su Park, Daejeon, KR;
Tae Suk Lee, Daejeon, KR;
Jong Koo Kang, Chungcheongbuk-do, KR;
Young Sik Jung, Seoul, KR;
Ki-Young Sohn, Seoul, KR;
Enzychem Lifesciences Corporation, Seoul, KR;
Korea Research Institute of Bioscience and Biotechnology, Daejeon, KR;
Abstract
The invention relates to pharmaceutical compositions, as well as health functional food compositions and quasi-drug compositions, for preventing, treating, or improving rheumatoid arthritis, comprising a monoacetyldiacylglycerol compound as an active ingredient. The monoacetyldiacylglycerol of the invention is effective in inhibiting the phosphorylation of STAT-3 known to be a therapeutic target for rheumatoid arthritis. As the monoacetyldiacylglycerol is an effective therapeutic agent without toxicity, the monoacetyldiacylglycerol can overcome the side effects of the medicines currently used in the treatment of rheumatoid arthritis. Thus, the monoacetyldiacylglycerol can be used for preventing, treating or improving rheumatoid arthritis.